Atlas Trials

Recurrent Glioblastoma Multiforme

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Glioblastoma Multiforme

RecordFirmDate
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma (NCT05868083)Shanghai Simnova Biotechnology Co.,Ltd.2022-06-24
A Prospective, Open-label, Single-arm Clinical Study (NCT04689087)Sun Yat-sen University2020-04-01
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer (NCT03423628)AstraZeneca2018-04-02
Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme (NCT01934361)Novartis Pharmaceuticals2014-02-28
Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma (NCT02062827)University of Alabama at Birmingham2013-11-25
Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients (NCT01738646)Duke University2013-01-01
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients (NCT01756729)NovoCure Ltd.2012-12-01
Procarbazine and Lomustine in Recurrent Glioblastoma (NCT01737346)Incheon St.Mary's Hospital2012-10-01
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors (NCT01576666)Novartis Pharmaceuticals2012-07-01
Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme (NCT01464177)Andre Tsin Chih Chen2011-10-01
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors (NCT00747253)Monteris Medical2008-08-01
CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan (NCT00562419)Adnexus, A Bristol-Myers Squibb R&D Company2007-10-01
Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM (NCT00597493)Duke University2007-09-01
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM) (NCT00481455)CASI pharmaceuticals, Inc.2007-04-01
Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme (NCT00509301)Peregrine Pharmaceuticals2006-11-01
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM) (NCT00379470)NovoCure Ltd.2006-09-01
Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors (NCT00071539)Teva Branded Pharmaceutical Products R&D, Inc.2003-10-01

Track Recurrent Glioblastoma Multiforme automatically

Every clearance here is in the API, with alerts when new ones post.